Abstract
Background and aims
Endoscopic ultrasound-guided tissue acquisition, including both fine-needle aspiration (EUS-FNA) and fine-needle biopsy (EUS-FNB), has been frequently performed to acquire samples from both pancreatic and non-pancreatic lesions. Still, the impact of the diagnostic yield between FNA and FNB is uncertain. We conducted this study to compare the diagnostic performance and accuracy of the 22-gauge FNA needles with the 22-gauge FNB needles in sampling solid pancreatic and non-pancreatic lesions.
Methods
This is a prospective multicenter study conducted on 465 cases presented with solid pancreatic or non-pancreatic lesions.
Results
Patients were 275 male and 190 females with a mean age of 59 years. Three-hundred twenty-seven patients had solid pancreatic lesions, while 138 had non-pancreatic lesions; 245 cases underwent EUS-FNA, and the remaining 211 cases underwent EUS-FNB. The presence of intact tissue core and sample adequacy was significantly higher in the FNB cases in solid pancreatic and non-pancreatic lesions. Blood contamination was significantly more in cell blocks and smears of EUS-FNA compared to that of EUS-FNB in solid pancreatic and non-pancreatic lesions. Based on histologic assessment of cell block only, EUS-FNB had more diagnostic accuracy (99%) than FNA (61%) (P-value < 0.005). However, cytological diagnosis by smears only showed no significant difference. The combined cytological and histological evaluation had 100% sensitivity, specificity, and accuracy.
Conclusion
EUS-FNA and EUS-FNB have comparable accuracy in diagnosing solid pancreatic and non-pancreatic lesions without ROSE. EUS-FNB is superior to EUS-FNA in acquiring intact tissue core and adequate samples with little blood contamination. Based on histological assessment (cell block/tissue core) only, EUS-FNA has less accuracy than EUS-FNB in diagnosing solid pancreatic lesions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Ahmed, Mohammed Yousri 2
; Ahmed, Marwa A. 2
; Elenin, Sameh Abou 3
; Abdel-latif, Abeer 1
; Farouk, Mahmoud 4
; Ameen, Mahmoud Gamal 5
; El-Habashi, Ahmed Hussein 2
; Elshaer, Mahasen Akram 6 ; Alzamzamy, Ahmed Elsayed 3
1 Kasr Al-Aini School of Medicine, Internal Medicine Department, Division of Gastroenterology and Hepatology, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
2 National Cancer Institute, Cairo University, Pathology Department, Cairo, Egypt (GRID:grid.7776.1) (ISNI:0000 0004 0639 9286)
3 Military Medical Academy, Department of Gastroenterology and Hepatology, Maadi Armed Forces Medical Complex, Cairo, Egypt (GRID:grid.489816.a) (ISNI:0000 0004 0452 2383)
4 Assiut University, Department of Tropical Medicine and Gastroenterology, Assiut, Egypt (GRID:grid.252487.e) (ISNI:0000 0000 8632 679X)
5 South Egypt Cancer Institute, Assiut University, Department of Oncological Pathology, Assiut, Egypt (GRID:grid.252487.e) (ISNI:0000 0000 8632 679X)
6 Ahmed Maher Teaching Hospital, Cairo, Egypt (GRID:grid.7776.1)





